GSK-1521498

DB12886InvestigationalSmall molecule

GSK1521498 has been used in trials studying the treatment of Obesity and Alcoholism.

Mechanism: Pharmacologically active on Mu-type opioid receptor
Curator reviewed
Formula / weight: C₂₄H₂₀F₂N₄ · 402.449 g/mol (avg)
Code names: GSK1521498

Resolves to

Compound

Structure

InChIKeyWIEDUMBCZQRGSY-UHFFFAOYSA-NSMILESFC1=CC(=CC(F)=C1CNC1CC2=CC=CC=C2C1)C1=CC=CC(=C1)C1=NNC=N1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with GSK-1521498, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.